Interim data from Takeda-led Phase 1/2 study indicates immune response consistent with Moderna’s Phase 3 COVE study Takeda will import…
Complimentary resources include localized online learning tools for healthcare professionals and the public in India on the prevention and management…
End-to-end 5G Private Network with Open RAN capabilities, cloud-enabled 5G Core, orchestration and analytics, and an ecosystem of device and…
SHENZHEN, China--(BUSINESS WIRE)--Wondershare, a leading digital software technology company is launching its affiliate program and is free for everyone to…
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi, “Meiji”) today announced that the…
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Recently, a 15-meter-high, 45-meter-wide giant screen in Dubai scrolled a poster with the theme of “Pineapple…
DAYTONA BEACH, Fla., May 20, 2021 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today…
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Immune Health Supplement Market–…
Conference will bring leaders in the style and beauty industries together to talk fashion, beauty, costume design, women’s empowerment, sustainability,…
Kaku et al. Long-term efficacy and safety in Phase 3 study with Imeglimin as mono- and add-on therapy in Japanese…